Evaluating safety in hyaluronic acid lip injections.
Safran T, Swift A, Cotofana S, Nikolis A.
Expert Opin Drug Saf. 2021 Dec;20(12):1473-1486. doi: 10.1080/14740338.2021.1962283. Epub 2021 Aug 19.
Complications of fillers in the lips and perioral area: Prevention, assessment, and management focusing on ultrasound guidance.
Kroumpouzos G, Harris S, Bhargava S, Wortsman X.
J Plast Reconstr Aesthet Surg. 2023 Sep;84:656-669. doi: 10.1016/j.bjps.2023.01.048. Epub 2023 Mar 7.
Efficacy and safety of corticosteroids, hyaluronic acid, and PRP and combination therapy for knee osteoarthritis: a systematic review and network meta-analysis.
Qiao X, Yan L, Feng Y, Li X, Zhang K, Lv Z, Xu C, Zhao S, Liu F, Yang X, Tian Z.
BMC Musculoskelet Disord. 2023 Nov 30;24(1):926. doi: 10.1186/s12891-023-06925-6.
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection.
Alam M, Kakar R, Dover JS, Harikumar V, Kang BY, Wan HT, Poon E, Jones DH.
JAMA Dermatol. 2021 Feb 1;157(2):174-180. doi: 10.1001/jamadermatol.2020.5102.
Complications following injection of soft-tissue fillers.
Ozturk CN, Li Y, Tung R, Parker L, Piliang MP, Zins JE.
Aesthet Surg J. 2013 Aug 1;33(6):862-77. doi: 10.1177/1090820X13493638. Epub 2013 Jul 3.
The Food and Drug Administration Safety Communication on Unintentional Injection of Soft-Tissue Filler Into Facial Blood Vessels: Important Points and Perspectives.
Jagdeo J, Hruza G.
Dermatol Surg. 2015 Dec;41(12):1372-4. doi: 10.1097/DSS.0000000000000547.
Complication of Soft Tissue Fillers: Prevention and Management Review.
Galadari H, Krompouzos G, Kassir M, Gupta M, Wollina U, Katsambas A, Lotti T, Jafferany M, Navarini AA, Vasconcelos Berg R, Grabbe S, Goldust M.
J Drugs Dermatol. 2020 Sep 1;19(9):829-832. doi: 10.36849/JDD.2020.10.36849/JDD.2020.5084.
Soft tissue injections.
Inês LP, da Silva JA.
Best Pract Res Clin Rheumatol. 2005 Jun;19(3):503-27. doi: 10.1016/j.berh.2005.01.003.
Intra-articular and soft-tissue corticosteroid injections and risk of infections: Population-based self-controlled-risk-interval design.
Zacay G, Heymann AD.
Pharmacoepidemiol Drug Saf. 2023 Jul;32(7):718-725. doi: 10.1002/pds.5602. Epub 2023 Feb 20.
Cymetra.
Maloney BP, Murphy BA, Cole HP 3rd.
Facial Plast Surg. 2004 May;20(2):129-34. doi: 10.1055/s-2004-861753.
